– with New Joint Venture Acquisition Hong Kong-headquartered and listed Far East Consortium International Limited’s (FEC, Stock Code: 35.HK) hotel…
Search Results: HKEX (379)
– and Continuing Training to Keep Up The Hong Kong Institute of Directors (HKIoD) welcomes(1) The Hong Kong Exchanges and…
– Contracts-in-hand at a High Level of Over HK$11,700 Million – Leverages Innovation and Operational Excellence – to Explore Synergistic…
Net profit margin maintained at 22.7% for the year with 15 new shop openings in Hong Kong and Mainland China…
Ching Lee Holdings Limited Ching Lee or The Group (HKG: 3728) announced its annual results for the year ended 31…
HighTide Therapeutics, Inc. (HKG: 2511), a clinical stage biopharmaceutical company specializing in the development of multi-targeted therapies for chronic liver…
Strategic Move for Exploring Korean and Overseas Market Opportunities Creating Synergies for Instant Noodle and Non-Noodle Businesses Nissin Foods Company…
Over the past few years, many Chinese corporations undergoing transformation and upgrading have experienced a rare “double whammy” in the…
Anticipates Not Less Than 120% Rise in Consolidated Profit Attributable to Shareholders JBM (Healthcare) Limited (JBM Healthcare or the Company;…
On April 20, the 2024 National Vaccines and Health Conference organized by the Chinese Preventive Medicine Association (CPMA) and the…
Captures Emerging Opportunities in Core Business Segments with Innovative Solutions Explores Potential Synergistic Business Opportunities to Accelerate Global Expansion Plan…
Yoho Group Holdings Limited (YOHO or the Group; HKG: 2347), a leading e-commerce platform in Hong Kong, is pleased to…
Ching Lee Holdings Limited Ching Lee or The Group (HKG: 3728) reported its 2023 Interim Results on Monday with a…
A resilient and sustainable growth with increase in profitability in consecutive years Perfect Medical Health Management Limited (the Company, HKG:…
China’s largest platform-centric decision-making AI company[1] – Beijing Fourth Paradigm Technology Co., Ltd. (HKG: 6682), today listed on the Main…
Hong Kong’s first ESG community with a dedicated physical space in the heart of Central; Facilitating cross-sector collaboration between impact…
Medical aesthetic segment achieved a revenue of RMB194.0 million Returned to high growth Significant R&D investment continued to effectively facilitate…
First-in-class glucokinase activator (GKA) HuaTangNing (dorzagliatin) was approved in China in September 2022. Since the launch of commercial sales at…
Ready to Capture Tremendous Opportunities in Post-Pandemic Era Leverage Innovation and “Go Global” Vision to Drive Sustainable Development Analogue Holdings…
Business and political leaders sign more than 30 MoUs in trade, investment, technology, infrastructure and cultural sectors The Hong Kong…